With Merck & Co. largely propping up supplies of the bladder cancer-fighting bacteria Bacillus Calmette-Guérin (BCG) in the U.S., ImmunityBio has received the FDA all-clear to help pick up the ...
FDA approves an expanded access program that would offer patients an alternative to Merck’s bladder cancer medication.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback